Recurrent myxoinflammatory fibroblastic sarcoma: a case report.
Niveditha Jagadesh1, Daniel H Miller1, William Schenk2
1Department of Radiation Oncology Mayo Clinic Jacksonville Florida.
Clinical Case Reports
|June 8, 2017
Summary
Myxoinflammatory fibroblastic sarcoma, a rare extremity cancer, is primarily treated with surgery. For recurrent cases, radiotherapy, including modern intensity-modulated techniques, shows promise for improved long-term outcomes.
Area of Science:
- Oncology
- Surgical Pathology
- Radiation Oncology
Background:
- Myxoinflammatory fibroblastic sarcoma (MFS) is a rare malignant neoplasm.
- MFS typically affects the extremities and is initially managed with surgical resection.


